Publications by authors named "E Poiasina"
Gastric glomus tumors (GGTs) are usually rare mesenchymal neoplasms. They are typically benign, with very few metastatic cases reported and no specific guidelines on their management. Here, we present a patient with a locally advanced GGT with synchronous liver metastases.
View Article and Find Full Text PDFArticle Synopsis
- Acute left colonic diverticulitis (ALCD) in the elderly differs from younger patients in terms of clinical presentation, higher mortality rates during hospitalization and after surgery, and increased risk from geriatric comorbidities.
- Despite these risks, elderly patients have a lower chance of recurrent episodes and less likelihood of needing urgent surgery if recurrence occurs.
- A recent workshop in Italy involving various medical organizations sought to develop age-specific guidelines for diagnosing and treating ALCD in older adults, concluding with expert-approved recommendations on diagnosis, management, surgical techniques, and antibiotic treatment.
Background: The eighth edition of the American Joint Committee on Cancer classifies nonmetastatic, node-negative colorectal cancers invading the submucosa (T1) and muscularis propria (T2) as stage I tumors without additional subclassification.
Objective: The aim of the study was to compare survival of T1N0M0 versus T2N0M0 colorectal cancers and to investigate factors associated with decreased survival.
Design: This was an analysis of 2 large population-based data sets.
Background: Acute calculus cholecystitis (ACC) has a high incidence in the general population. The presence of several areas of uncertainty, along with the availability of new evidence, prompted the current update of the 2016 WSES (World Society of Emergency Surgery) Guidelines on ACC.
Materials And Methods: The WSES president appointed four members as a scientific secretariat, four members as an organization committee and four members as a scientific committee, choosing them from the expert affiliates of WSES.
Article Synopsis
- Recent research shows that mutations in the KRAS gene (m-KRAS) negatively impact survival rates in patients with metastatic colorectal cancer undergoing treatment.
- The study analyzed data from 806 patients to identify risk factors for m-KRAS, finding that right-sided tumors and African-American ethnicity were significant predictors of this mutation.
- Patients with m-KRAS had lower disease-specific survival rates (DSS) compared to those with the normal KRAS gene (wt-KRAS), indicating its role as a negative prognostic factor alongside the location of the tumors.